Physician profile
Richard Dutton
NPI 1215973516
$104,860.56
in general payments reported to CMS, 2019-2025
11 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2021: $30K · 2022: $9,851 · 2023: $22K · 2024: $9,079 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,450 · Travel and Lodging: $5,980 · Food and Beverage: $1,755 · Honoraria: $1,700 · Gift: $50.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,565.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,450.00 |
| Travel and Lodging | $5,980.49 |
| Food and Beverage | $1,754.56 |
| Honoraria | $1,700.00 |
| Gift | $50.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerus Corporation | $35,304.86 | 2021-2025 | Intercept Blood System For Cryoprecipitation, Intercept Blood System For Platelets |
| Merck Sharp & Dohme LLC | $20,316.98 | 2019-2024 | Bridion |
| Becton, Dickinson and Company | $18,854.53 | 2021-2022 | |
| Eagle Pharmaceuticals, INC. | $8,200.00 | 2023 | |
| Acacia Pharma INC | $8,117.84 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $6,140.85 | 2024-2025 | |
| Medtronic, INC. | $4,738.17 | 2022-2023 | Mcgrath Mac |
| Edwards Lifesciences Corporation | $3,071.51 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $72.26 | 2022-2025 | Exparel, Iovera |
| Heron Therapeutics, INC. | $29.89 | 2023 | Zynrelef |
| Fisher & Paykel Healthcare INC | $13.67 | 2024 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.